Reliance Pharmaceuticals, the proposed pharmaceutical manufacturing company promoted by Mukesh Ambani's Reliance Life Sciences, will soon rope in a consultant to give final shape to the project, slated to take off within two years.
In a tribute, President Joe Biden called him a "born patriot", while Indian External Affairs Minister S Jaishankar hailed him as a thought-provoking global strategist.
Competing with established biotech companies in India such as Wockhardt, Biocon and Reliance Life Sciences, small biotech companies such as Zenotech, BV Biocorp and Intas Biopharma are likely to emerge as major players in biogeneric drugs.
India is attempting to soft-land a rover on the moon and will attempt, at some point next year hopefully, sending humans into orbit. All of this makes an exciting time for space around the world, notes Aakar Patel.
It's raining sequels and true stories on OTT this week. Sukanya Verma lists everything you can watch.
Global pharma and biotech companies, especially those from US, Europe and Japan, are keen to sign agreements with Indian companies, according to experts.
Security presence which has been bolstered by flying in more army troops and rapid action force and central police forces was clearly visible at all major areas and roads.
Despite news of the private equity in the domestic healthcare and pharma industry touching almost Rs 40 crore (Rs 40 million) in the first nine months of the year, PE firms are not exactly bullish about investing in the pharma industry alone. In fact, a closer look at the investments reveals that a larger part of the money is being flown into healthcare delivery systems like hospital chains and not in pharma companies.
'Does anyone understand India?' 'Does anyone have a larger perspective for India as a whole?' 'Today we have rulers who do not understand the ruled.'
For Yoginder, it is a release from pain. But for us, his friends, it is the loss of a warm and generous life companion, says Nitin Desai of his 50-year association with the eminent economist who passed into the ages on December 6, 2022.
S Bhaskaran is the first bodybuilder to be presented the Arjuna Award in 20 years.
Suven Life Sciences Ltd has signed an agreement with US-based pharmaceutical firm Eli Lilly and Company to carryout pre-clinical research for central nervous system disorder.
Software services firm Netkraft on Thursday said it is being acquired by the privately held business process and technology consulting company, the United States-based Adea Solutions, in an all-cash deal.
Hiring for management professionals with greater than 16 years of experience witnessed a spike of 66% compared to last year.
Hyderabad is fast emerging as destination for pharma and bio-tech industries with projected growth of 30 to 40 per cent, consultant company Frost and Sullivan has said.
Stories of rural India, campus capers, realistic family dramas and urban romance that are no longer picked up by film-makers, find their way to the Web, and the viewing experience is richer for the variety available.
The primary market is set for a bumper Rs 80,000-crore bonanza with 30 companies already filing IPO papers to raise Rs 55,000 crore, while around 10 more are lined up for this month itself, seeking to mop up another Rs 25,000 crore, say investment bankers. The market has been on a non-stop rally, hitting new records almost every week, on the back of an influx of investors -- a vast majority of them first-timers -- coupled with a flood of liquidity. Foreign funds alone had pumped in a record $35 billion into the market in FY21, while the trend has continued this fiscal as well. Domestic institutions led by LIC have also infused trillions of rupees, helping woo retail investors in troves -- the year saw over 20 million new investors coming to the market.
India, with its strong research and development base in life sciences, IT and pharma industries, is on the threshold of a revolution in biotechnology, scientists at the BioAsia 2004 Summit said in Hyderabad on Thursday.
Indian companies are likely to shell out an average salary increment of 10.3 per cent in the current fiscal with employees in pharma, health care and life sciences projected to get 12.4 per cent raise, says a survey.
Corporate India handed over an average increment of 8 per cent in 2021, and early estimates reveal that average increment for 2022 is expected to increase to 8.6 per cent in line with a healing economy and improving confidence, according to a Deloitte survey. As per the second phase of Deloitte's Workforce and Increment Trends survey 2021, 92 per cent companies gave an increment in 2021 at an average of 8 per cent, compared with only 4.4 per cent in 2020, where just 60 per cent companies had extended a pay hike. For 2022, average increment is expected to increase to 8.6 per cent, at par with the pre-pandemic levels of 2019, the survey said, adding that about 25 per cent companies surveyed have projected a double-digit increment for 2022.
Nittany, the healthcare BPO firm, is looking for a Professional Medical Coder.
Wipro's clients currently include over 100 US payers, healthcare providers, and public health agencies.
Antony, who headed the digital media cell of the Kerala Pradesh Congress Committee, slammed the Congress leadership for working for a "single family" instead of working for the country.
Interview with V Balakrishnan, Former CFO and board member of Infosys and AAP leader
'Essentially there are three things the government should be doing: Identify who you are going to get your vaccine from, figure out how you are going to pay for it, and figure out how you're going to deliver it and to whom.'
Suven Pharmaceuticals' wholly owned subsidiary, Suven Life Sciences USA, has acquired the assets of the US-based Synthon Chiragenics, according to a release issued by Suven Pharmaceuticals to the BSE on Tuesday.
Shanghvi needs to deploy this excess cash.
Had he not taken his final curtain call on April 23, 1992, Satyajit Ray would still, undoubtedly, have been making movies.
The Reliance group is planning to buy the plastics business of a well-known company in Pakistan for about $300 million, industry sources said on Monday.
The deluge of offerings in the primary market, a muted results season and increasing talks of a Fed taper may quicken the pace of overseas investors selling Indian equities in the near term. The next few weeks may see a dozen companies tap the market for initial public offerings and raise about Rs 30,000 crore. These include the likes of Zomato, Glenmark Life Sciences, Utkarsh Small Finance Bank and Seven Islands Shipping.
According to various global media reports, China is creating Covid-like pathogens in Pakistan that have the potential of causing virus contamination on a scale far higher than Covid.
Announcing its unique recruitment model, eLitmus.com, promoted by IT recruitment firm Browse Consulting, has said that it had signed up with 53 companies in IT, BPO, banking and financial cervices and life science sectors to hire 7500 fresh graduates
Meet the world's top venture capitalists, the early investors behind some of the biggest IPOs on the planet.
A seasonally-strong quarter, with no immediate impact of the second wave and continued acceleration of digital transformation will allow the IT services sector to report a robust Q1 this financial year. However, key metrics to look out for will be attrition rate and margin lever as they will be impacted by salary hikes. Analysts expect growth for the quarter to be broad-based, with sectors like banking, financial services and insurance (BFSI), retail, manufacturing, hi-tech and life sciences driving revenue growth. Analysts across brokerage houses are pegging revenue growth in the range of 1.5 per cent to 4.5 per cent.
IT firm Nucleaus Software Exports on Tuesday said it has featured in the Deloitte Technology's ranking of the Fast 500 companies in Asia Pacific. \n
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances